Evonik agrees to sell its methacrylate business for € 3 billion
Evonik signed an agreement to sell its methacrylates business for € 3 billion ($ 3.4 billion) to Advent International. The sales price is 8.5 times the EBITDA of the business. The transaction is subject to regulatory approvals in various countries and is due to close in the third quarter of this year. Globally, Evonik’s methacrylates … Read more